In a powerful statement of disagreement with the FDA’s approval of Biogen’s controversial Alzheimer’s drug, three scientists have resigned from the independent committee that advised the agency on the treatment. https://t.co/Y7J2YmKkZN
35
155
351
Replies
@nytimes So the company is charging 56k to scam people. Nice.
1
1
5
@nytimes “This might be the worst approval decision that the F.D.A. has made that I can remember,” said Dr. Aaron Kesselheim, a professor of medicine at Harvard Medical School and Brigham and Women’s Hospital. Serious side effects, ppl, and no data suggesting it works as claimed.
2
1
13
@nytimes Strange, FDA .. is still sitting on approval of mRNA vaccines but has no problem approving a controversial drug??
0
0
5
@nytimes It’s profit over science, typical
0
1
8
@nytimes Follow the money 💴
0
0
1
0
0
1
@nytimes FDA is like the bug in attractive outfit. They've been quietly wrecking people's health through the years. And, gas prices has been hung up high and looking normal to everyone and no one is talking... Seems FDA endorsed that too?
0
0
1